International Standard
ISO 22442-3:2007
Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Reference number
ISO 22442-3:2007
Edition 1
2007-12
International Standard
Read sample
p
ISO 22442-3:2007
39351
Published (Edition 1, 2007)
This standard was last reviewed and confirmed in 2022. Therefore this version remains current.

ISO 22442-3:2007

ISO 22442-3:2007
39351
Format
Language
CHF 129
Convert Swiss francs (CHF) to your currency

Abstract

ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.

General information

  •  : Published
     : 2007-12
    : International Standard confirmed [90.93]
  •  : 1
     : 22
  • ISO/TC 194
    11.100.20 
  • RSS updates

Life cycle

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)